kifunensine has been researched along with Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, CH; Chang, HC; Chien, YC; Chiu, WT; Chong, LW; Lin, YM; Su, HC; Sun, HY; Tsao, CW; Young, KC | 1 |
| Kato, T; Masaki, T; Matsuura, Y; Muhammad, A; Saeed, M; Suzuki, R; Suzuki, T; Tomonaga, M; Wakita, T; Watanabe, H; Watanabe, N | 1 |
2 other study(ies) available for kifunensine and Hepatitis C
| Article | Year |
|---|---|
Calcitriol Inhibits HCV Infection via Blockade of Activation of PPAR and Interference with Endoplasmic Reticulum-Associated Degradation.
Topics: Active Transport, Cell Nucleus; Alkaloids; Calcitriol; Cell Line, Tumor; Cell Nucleus; Clusterin; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum-Associated Degradation; Gene Expression Regulation; Heat-Shock Proteins; Hepacivirus; Hepatitis C; Humans; Lipid Metabolism; Nitric Oxide; Peroxisome Proliferator-Activated Receptors; Receptors, Calcitriol; Signal Transduction; Viral Core Proteins | 2018 |
Role of the endoplasmic reticulum-associated degradation (ERAD) pathway in degradation of hepatitis C virus envelope proteins and production of virus particles.
Topics: Alkaloids; Animals; Cell Line, Tumor; Endoplasmic Reticulum; Endoplasmic Reticulum-Associated Degradation; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Humans; Intracellular Membranes; Membrane Proteins; Mice; Protein Binding; Protein Transport; Proteins; Ubiquitination; Viral Envelope Proteins; Virion | 2011 |